2.09
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
MACD Signal: Can Neumora Therapeutics Inc stock beat market expectations this quarterJuly 2025 Update & Verified Chart Pattern Signals - BỘ NỘI VỤ
Can Neumora Therapeutics Inc. stock weather global recession2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
How Neumora Therapeutics Inc. stock reacts to job market dataQuarterly Trade Review & Free Accurate Trade Setup Notifications - Newser
Is Neumora Therapeutics Inc. stock attractive for ETFsPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital - MSN
What momentum indicators show for Neumora Therapeutics Inc. stockGold Moves & Safe Capital Investment Plans - Newser
Neumora Therapeutics (NMRA) Stock Analysis Report | Financials & Insights - Benzinga
Neumora Therapeutics stock rating upgraded by RBC Capital on NLRP3 potential - Investing.com Canada
Neumora Therapeutics Shares Rise After RBC Upgrade - marketscreener.com
Neumora upgraded at RBC Capital Markets on obesity, Parkinson's asset (NMRA:NASDAQ) - Seeking Alpha
Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline - Benzinga
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
RBC Capital Upgrades Neumora Therapeutics (NMRA) - Nasdaq
RBC Upgrades Neumora Therapeutics to Outperform From Sector Perform, Raises Price Target to $7 From $4, Keeps Speculative Risk - marketscreener.com
Can Neumora Therapeutics Inc. stock beat market expectations this quarterWeekly Market Report & Low Risk Profit Maximizing Plans - BỘ NỘI VỤ
What drives Neumora Therapeutics Inc stock priceIPO Market Watch & Outstanding Portfolio Tips - earlytimes.in
Neumora Therapeutics (NMRA) Price Target Increased by 21.43% to 8.67 - MSN
AlphaCore Capital LLC Invests $248,000 in Neumora Therapeutics, Inc. $NMRA - MarketBeat
Neumora Therapeutics thanks stakeholders for supporting brain disease therapy mission - Traders Union
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of "Hold" by Analysts - MarketBeat
Neumora Issues Shares Following Loan Conversion Notice - MSN
FINAL REMINDER NMRA DEADLINE: Bronstein, Gewirtz & Grossman LLC A - The National Law Review
How Neumora Therapeutics Inc. stock trades before earningsPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
How Neumora Therapeutics Inc. stock reacts to oil pricesJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com
Is Neumora Therapeutics Inc. stock oversold or undervalued2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Chart overlay techniques for tracking Neumora Therapeutics Inc.Trade Entry Summary & Proven Capital Preservation Methods - newser.com
Neumora Therapeutics price target raised to $3 from $2 at Stifel - MSN
What momentum shifts mean for Neumora Therapeutics Inc.Quarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Can Neumora Therapeutics Inc. stock maintain growth trajectoryGlobal Markets & Accurate Trade Setup Notifications - newser.com
How to build a custom watchlist for Neumora Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Is Neumora Therapeutics Inc. stock a safe investment in uncertain marketsIndex Update & Risk Controlled Daily Trade Plans - newser.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com India
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Neumora Therapeutics (NASDAQ:NMRA) Price Target Raised to $3.00 at Stifel Nicolaus - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):